Fig. 2From: Indicators of suboptimal response to anti-tumor necrosis factor therapy in patients from China with inflammatory bowel disease: results from the EXPLORE studyFirst indicators of suboptimal response to first-line anti-TNF therapy in patients with IBD in China. IBD inflammatory bowel disease, TNF tumor necrosis factorBack to article page